Recombinant Bovine GJD2 Protein ，His & SUMO

GJD2, also known as Connexin 47 (Cx47), is a member of the connexin family of proteins, which form gap junctions facilitating intercellular communication. This protein is predominantly expressed in oligodendrocytes within the central nervous system and plays a crucial role in myelination and maintaining the integrity of the blood-brain barrier. The study of GJD2 is significant due to its potential implications in various neurological disorders, including multiple sclerosis and leukodystrophies, where impaired oligodendrocyte function disrupts myelin formation and signaling. Research into GJD2 recombinant protein seeks to better understand its structure-function relationships and the mechanisms underlying its role in cell communication. By producing GJD2 in a recombinant form, scientists can investigate its interactions with other cellular proteins and its impact on cell signaling pathways. Furthermore, GJD2's involvement in disease processes makes it a potential target for therapeutic strategies aimed at restoring normal function in pathological conditions. Understanding the molecular dynamics of GJD2 can also provide insights into the design of drug candidates aimed at enhancing or modulating gap junction communication, ultimately contributing to the development of innovative treatments for demyelinating diseases. Thus, the study of GJD2 recombinant protein represents a critical intersection of molecular biology, pathology, and therapeutic innovation.